v-ErbA is a mutated variant of thyroid hormone receptor (TR alpha /NR1A1) borne by the Avian Erythroblastosis virus causing erythroleukemia. TR alpha is known to activate transcription of specific genes in the presence of its cognate ligand, T3 hormone, while in its absence it represses it, v-ErbA is unable to bind ligand, and hence is thought to contribute to leukemogenesis by actively repressing erythroid-specific genes such as the carbonic anhydrase II gene (CA II). In the prevailing model, v-ErbA occludes liganded TR from binding to its cognate elements and constitutively interacts with the corepressors NCoR/ SMRT. We previously identified a v-ErbA responsive element (VRE) within a DNase I hypersensitive region (HS2) located in the second intron of the CA II gene. We now show that HS2 fulfils all the requirements for a genuine enhancer that functions independent of its orientation and position with a profound erythroid-specific activity in normal erythroid progenitors (T2ECs) and in leukemic erythroid cell lines. We find that the HS2 enhancer activity is governed by two adjacent GATA-factor binding sites. v-ErbA as well as unliganded TR prevent HS2 activity by nullifying the positive function of factors bound to GATA-sites. However, v-ErbA, in contrast to TR, does not convey active repression to silence the transcriptional activity intrinsic to a heterologous tk promoter. We propose that depending on the sequence and context of the binding site, v-ErbA contributes to leukomogenesis by occluding liganded TR as well as unliganded TR thereby preventing activation or repression, respectively.

The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer / G.G. Braliou, P. Ciana, W. Klaassen, O. Gandrillon, H. Stunnenberg. - In: ONCOGENE. - ISSN 0950-9232. - 20:7(2001), pp. 775-787.

The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer

P. Ciana
Secondo
;
2001

Abstract

v-ErbA is a mutated variant of thyroid hormone receptor (TR alpha /NR1A1) borne by the Avian Erythroblastosis virus causing erythroleukemia. TR alpha is known to activate transcription of specific genes in the presence of its cognate ligand, T3 hormone, while in its absence it represses it, v-ErbA is unable to bind ligand, and hence is thought to contribute to leukemogenesis by actively repressing erythroid-specific genes such as the carbonic anhydrase II gene (CA II). In the prevailing model, v-ErbA occludes liganded TR from binding to its cognate elements and constitutively interacts with the corepressors NCoR/ SMRT. We previously identified a v-ErbA responsive element (VRE) within a DNase I hypersensitive region (HS2) located in the second intron of the CA II gene. We now show that HS2 fulfils all the requirements for a genuine enhancer that functions independent of its orientation and position with a profound erythroid-specific activity in normal erythroid progenitors (T2ECs) and in leukemic erythroid cell lines. We find that the HS2 enhancer activity is governed by two adjacent GATA-factor binding sites. v-ErbA as well as unliganded TR prevent HS2 activity by nullifying the positive function of factors bound to GATA-sites. However, v-ErbA, in contrast to TR, does not convey active repression to silence the transcriptional activity intrinsic to a heterologous tk promoter. We propose that depending on the sequence and context of the binding site, v-ErbA contributes to leukomogenesis by occluding liganded TR as well as unliganded TR thereby preventing activation or repression, respectively.
Carbonic anhydrase II; Erythroid enhancer; GATA-sites; Repression; Thyroid hormone; v-ErbA
Settore BIO/14 - Farmacologia
Settore BIO/18 - Genetica
2001
Article (author)
File in questo prodotto:
File Dimensione Formato  
Braliou et al Oncogene 2001.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 244 kB
Formato Adobe PDF
244 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/203007
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact